Document:

Amendment number 2 to AHCA Contract No. FAR001

    
      

    

    Back
      to Form 10-Q

    Exhibit
      10.12

     

    
      
        	 HealthEase Health Plan of
                Florida, Inc. 	
                 Medicaid
                  HMO
                  Contract

              

      

       

      AHCA
        CONTRACT NO. FAR001

      AMENDMENT
        NO. 2

      

      THIS
        CONTRACT, entered into between the STATE OF FLORIDA, AGENCY FOR HEALTH CARE
        ADMINISTRATION, hereinafter referred to as the “Agency” and HEALTHEASE HEALTH
        PLAN OF FLORIDA, INC. hereinafter referred to as the “Vendor”, is hereby amended
        as follows:

      

      
        	
                1.

              	
                Standard
                  Contract, Section III, Item C., Contract Managers, sub-item 2.
                  is hereby
                  amended to now read as follows:

              

      

      

      2.
         The
        Vendor’s Contract Manager’s name, address and telephone number for this Contract
        is as follows:

      

      Geoffrey
        L. Petrie

      HealthEase
        Health Plan of Florida, Inc.

      8735
        Henderson Road

      Tampa,
        FL
        33614-3988

      (813)
        865-5038

      

      
        	
                2.
                  

              	
                Attachment
                  II, Medicaid Reform Health Plan Model Contract, Section IV., Behavioral
                  Health Care, Item Q., Community Behavioral Health Services Annual
                  80/20
                  Expenditure Report, as included by Amendment No. 1 to this Contract,
                  is
                  hereby deleted in its entirety.

              

      

      

      
        	
                3.

              	
                Attachment
                  II, Medicaid Reform Health Plan Model Contract, Section XII., Reporting
                  Requirements, as replaced by Amendment No. 1 to this Contract,
                  Item A.,
                  Health Plan Reporting Requirements, Table 1, Summary of Reporting
                  Requirements, is hereby revised to delete in its entirety, the
                  last row of
                  the table containing the data set requirements for the report entitled
                  “Behavioral Health: Annual 80/20 Expenditure
                  Report.”

              

      

      

      All
        provisions in the Contract and any attachments thereto in conflict with this
        Amendment shall be and are hereby changed to conform with this
        Amendment.

      

      All
        provisions not in conflict with this Amendment are still in effect and are
        to be
        performed at the level specified in the Contract.

      

      This
        Amendment is hereby made part of the Contract.

      

      This
        Amendment cannot be executed unless all previous Amendments to this Contract
        have been fully executed.

      

      IN
        WITNESS WHEREOF, the parties hereto have caused this one (1) page Amendment
        to
        be executed by their officials thereunto duly authorized.

      

      
        	
                HEALTHEASE
                  HEALTH PLAN OF FLORIDA, INC.

              	
                STATE
                  OF FLORIDA, AGENCY FOR HEALTH CARE
                  ADMINISTRATION

              
	
                Signed
                  by:    /s/
                  Todd S. Farha         
                   

              	
                Signed
                  by:   /s/
                  Andrew Agwunobi, M.D.   

              
	
                Name:
                  Todd S. Farha

              	
                Name:
                  Andrew C. Agwunobi, M.D.

              
	
                Title:
                  President and CEO

              	
                Title:
                  Secretary

              
	
                Date:
                  4/19/2007

              	
                Date:
                  4/26/07

              

      

       

      AHCA
        CONTRACT NO. FAR001, Amendment No. 2, Page 1 of
        1Amendment number 2 to AHCA Contract No. FAR009

    
      

    

    Back
      to Form 10-Q

    Exhibit
      10.13

     

    
      
        	
                WellCare
                  of Florida, Inc.

                d/b/a
                  Staywell Health Plan of Florida, Inc.

              	
                Medicaid
                  HMO Contract

              

      

          

      AHCA
        CONTRACT NO. FAR009

      AMENDMENT
        NO. 2

      

      THIS
        CONTRACT, entered into between the STATE OF FLORIDA, AGENCY FOR HEALTH CARE
        ADMINISTRATION, hereinafter referred to as the “Agency” and WELLCARE OF FLORIDA,
        INC. D/B/A STAYWELL HEALTH PLAN OF FLORIDA, hereinafter referred to as the
        “Vendor”, is hereby amended as follows:

      

      
        	
                1.

              	
                Standard
                  Contract, Section III, Item C., Contract Managers, sub-item 2.
                  is hereby
                  amended to now read as follows:

              

      

      

      2.
         The
        Vendor’s Contract Manager’s name, address and telephone number for this Contract
        is as follows:

      

      Geoffrey
        L. Petrie

      WellCare
        of Florida, Inc.

      d/b/a
        Staywell Health Plan of Florida

      8735
        Henderson Road

      Tampa,
        FL
        33614-3988

      (813)
        865-5038

      

      
        	
                2.
                  

              	
                Attachment
                  II, Medicaid Reform Health Plan Model Contract, Section IV., Behavioral
                  Health Care, Item Q., Community Behavioral Health Services Annual
                  80/20
                  Expenditure Report, as included by Amendment No. 1 to this Contract,
                  is
                  hereby deleted in its entirety.

              

      

      

      
        	
                3.

              	
                Attachment
                  II, Medicaid Reform Health Plan Model Contract, Section XII., Reporting
                  Requirements, as replaced by Amendment No. 1 to this Contract,
                  Item A.,
                  Health Plan Reporting Requirements, Table 1, Summary of Reporting
                  Requirements, is hereby revised to delete in its entirety, the
                  last row of
                  the table containing the data set requirements for the report entitled
                  “Behavioral Health: Annual 80/20 Expenditure
                  Report.”

              

      

      

      All
        provisions in the Contract and any attachments thereto in conflict with this
        Amendment shall be and are hereby changed to conform with this
        Amendment.

      

      All
        provisions not in conflict with this Amendment are still in effect and are
        to be
        performed at the level specified in the Contract.

      

      This
        Amendment is hereby made part of the Contract.

      

      This
        Amendment cannot be executed unless all previous Amendments to this Contract
        have been fully executed.

      

      IN
        WITNESS WHEREOF, the parties hereto have caused this one (1) page Amendment
        to
        be executed by their officials thereunto duly authorized.

      

      
        	
                WELLCARE
                  OF FLORIDA, INC. D/B/A STAYWELL HEALTH PLAN OF
                  FLORIDA

              	
                STATE
                  OF FLORIDA, AGENCY FOR HEALTH CARE
                  ADMINISTRATION

              
	
                Signed
                  by:   /s/
                  Todd S. Farha        
                  

              	
                Signed
                  by:  /s/
                  Andrew Agwunobi, M.D.   

              
	
                Name:
                  Todd S. Farha

              	
                Name:
                  Andrew C. Agwunobi, M.D.

              
	
                Title:
                  President and CEO

              	
                Title:
                  Secretary

              
	
                Date:
                  4/19/2007

              	
                Date:
                  4/26/07

              

      

      

      AHCA
        CONTRACT No. FAR009, Amendment No. 2, Page 1 of 1Exhibit 10.34

     

    
      Exhibit
        10.34

      

      Aspreva
        Pharmaceuticals Corporation

      

      2007
        DISCRETIONARY VARIABLE COMPENSATION PLAN 
        
          

        

      

      

       

      The
        2007 Aspreva Pharmaceuticals Discretionary Variable Compensation Plan (the
“2007
        Plan”) is applicable to executive officers and other senior officers of Aspreva
        Pharmaceuticals Corporation (the “Participants”). Each Participant is eligible
        to receive an incentive as cash, calculated as a percentage of the Participant’s
        base salary.

       

      Variable
        Cash Compensation 

       

      Under
        the 2007 Plan, a variable cash compensation payment will be paid to the
        Participants if: 

      

      (a)   
        in
        the opinion of the Compensation Committee, Aspreva meets or exceeds any pre-set
        threshold or target or trigger objectives as proposed by the Senior Leadership
        Team, recommended by the 

        Compensation
        Committee,
        and agreed by the Board of Directors. 

      

      For
        2007, the 2007 Plan requires that Aspreva complete at least one transaction
        consistent with corporate strategy as a minimum threshold before Participants
        are eligible to earn an incentive payment under the 2007 Plan:

       

      (b)    if
        the pre-set threshold or trigger is met, the size of any variable cash
        compensation will be based on two performance components: (i) the overall
        assessment of corporate performance within 2007 

              
        and (ii) whether and/or to what degree individuals achieve their individual
        objectives.

      

      For
        2007, a Participant’s Target Payment is comprised of two performance components:
        (i) forty percent (40%) is based upon the achievement of corporate
        objectives and (ii) sixty percent (60%) is based upon the achievement of
        personal objectives.

      

      The
        Target Bonus levels are reviewed and set annually for each Participant. The
        Target Bonuses for Aspreva’s executive officers for 2007 are set forth
        below:

      

      
        	
                Executive
                  Officer

              	
                 

              	
                Title

              	
                 

              	
                Target

                Bonus

              
	
                Richard
                  M. Glickman

              	
                 

              	
                Chief
                  Executive Officer

              	
                 

              	
                50

              	
                %

              
	
                Noel
                  F. Hall

              	
                 

              	
                President
                  

              	
                 

              	
                50

              	
                %

              
	
                Bruce
                  G. Cousins

              	
                 

              	
                Executive
                  Vice President and Chief Financial Officer

              	
                 

              	
                40

              	
                %

              
	
                Charles
                  F. Goulburn

              	
                 

              	
                Executive
                  Vice President, Global Pharmaceutical Operations 

              	
                 

              	
                40

              	
                %

              
	
                Richard
                  Jones 

              	
                 

              	
                Chief
                  Scientific Officer

              	
                 

              	
                35

              	
                %

              
	
                Azam
                  Usman

              	
                 

              	
                Chief
                  Medical Officer 

              	
                 

              	
                35

              	
                %

              

      

      

      

      Example:
        with a salary of $200,000 and a 40% Target Bonus - the total potential variable
        cash payment would be $80,000, calculated with 40% allocated to corporate
        objectives, or $32,000, and 60% allocated to individual objectives, or $48,000.
        

      

      Corporate
        objectives and individual objectives are determined independently of each
        other.
        Once added together they form the Participant’s aggregate variable cash
        payment.

      

      Each
        component of the 2007 Plan allows for under performance, on target performance
        and over performance. The minimum payment is 0% for both components. On target
        performance allows a payment of up to 100% of each component. For performances
        which are deemed to exceed the target, each component is capable for payments
        up
        to 115%. (see below)

       

      Corporate
        Objectives Variable Payment: Depending
        upon the opinion of the Compensation Committee and their determination of
        how
        whether and well corporate objectives have been met, each Participant’s
        corporate variable payment is calculated as follows: 

       

       

      Corporate
        Variable Payment = Salary x Target Bonus (40%) x corporate achievement score
        (0
        to 115%)

       

      Individual
        Objectives Variable Payment: Depending
        upon the opinion of the Compensation Committee and their determination of
        whether and how well individual objectives have been addressed, each
        Participant’s personal variable payment is calculated as follows: 

       

      Individual
        Corporate Payment = Salary x Target Bonus (60%) x individual achievement
        score
        (0 to 115%)

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      Corporate
        Objectives for 2007

       

      Establish
        5 year Corporate Strategy & Plan 

      

      Business
        Development 

      

      
        	 	
                •

              	
                Complete
                  transactions consistent with corporate
                  strategy

              

      

      

      Clinical
        Development & Regulatory Affairs

      

      
        	 	
                •

              	
                Complete
                  ALMS induction study in the second quarter of
                  2007

              

      

      
        	 	
                •

              	
                Strengthen
                  and align Roche/Aspreva resources in support of a Lupus Nephritis
                  supplemental New Drug Application filing with the U.S. Food and
                  Drug
                  Administration in the fourth quarter of
                  2007

              

      

      
        	 	
                •

              	
                Maintain
                  high standards of cGCP 

              

      

      
        	 	
                •

              	
                Develop
                  innovative discovery and de-risking capability for early stage
                  assets

              

      

      

      Pharma
        Operations

      

      
        	 	
                •

              	
                Strengthen
                  global medical affairs programs, including delivery of ALMS global
                  publication plan, 

              

      

      
        	 	
                •

              	
                Build-out
                  “innovative” commercial capability, proactively supporting business
                  development initiatives

              

      

      

      General
        and Administrative

      

      
        	 	
                •

              	
                Instil
                  and maintain Sarbanes-Oxley compliancy throughout Aspreva
                  

              

      

      
        	 	
                •

              	
                Execution
                  of information technology strategy, deploying foundational capabilities
                  to
                  the business

              

      

      
        	 	
                •

              	
                Strengthen
                  human capital programs &
services

              

      

      

      All
        programs designed with three key tenets:

      

      
        	 	
                •

              	
                Exceed
                  partner expectations 

              

      

      
        	 	
                •

              	
                Create
                  long term shareholder value through sustainability and
                  profitability

              

      

      
        	 	
                •

              	
                Operate
                  in a fashion consistent with our values of being “beyond compliance”
                  

              

      

       

      Individual
        Objectives for 2007

       

      Individual
        objectives are proposed by the Chief
        Executive Officer for
        all Participants and are evaluated by the Compensation Committee for the
        Chief
        Executive Officer and are guided by the Chief Executive Officer in the case
        of
        other Participants. A final determination of such objectives is made by the
        Board of Directors.

       

      Miscellaneous
        Provisions

       

       

      Payments
        under the 2007 Plan shall be made following the end of the fiscal year, on
        such
        schedule as may be approved by the Compensation Committee in its discretion.
        

       

       

      Participation
        in the 2007 Plan shall not alter in any way the at will nature of Aspreva’s
        employment of a Participant, and such employment may be terminated at any
        time
        for any reason, with or without cause and with or without prior notice.

       

       

      The
        Board of Directors or the Compensation Committee may amend or terminate the
        2007
        Plan at any time. Further, the Board of Directors or the Compensation Committee
        may modify any provision of the 2007 Plan at any time.

       

       

      The
        2007 Plan shall be governed by and construed in accordance with the laws
        of
        British Columbia, Canada.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}]]